← All trials
NCT01088841
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2009
- Primary completion
- Jan 31, 2010
- Completion date
- Mar 31, 2010
- First posted
- Mar 17, 2010
- Last posted
- Feb 23, 2011
- Enrollment
- 16
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of BaselLead sponsor
- University of BaselOverall official - principal investigator
- University of BaselSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.